| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1930994 | Biochemical and Biophysical Research Communications | 2010 | 5 Pages |
Evodiamine, the major bioactive alkaloid isolated from Wu-Chu-Yu, has been shown to interact with a wide variety of proteins and modify their expression and activities. In this study, we investigated the interaction between evodiamine and the aryl hydrocarbon receptor (AhR). Molecular modeling results revealed that evodiamine directly interacted with the AhR. Cytosolic receptor binding assay also provided the evidence that evodiamine could interact with the AhR with the Ki value of 28.4 ± 4.9 nM. In addition, we observed that evodiamine suppressed the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced nuclear translocation of the AhR and the expression of CYP1A1 dose-dependently. These results suggested that evodiamine was able to bind to the AhR as ligand and exhibit antagonistic effects.
Research highlights► Evodiamine interacted with the AhR. ► Evodiamine inhibited the specific binding of [3H]–TCDD to the AhR. ► Evodiamine acts as an antagonist of the AhR.
